Trials / Not Yet Recruiting
Not Yet RecruitingNCT06805500
Robotic Assisted Balance and Exoskeleton Training (REACTION) in Neurorehabilitation: a Feasibility Study
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Roessingh Research and Development · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to explore the effect on walking speed of a new robotic assisted balance and gait trainer (REACTION) and their subsystems in individuals with neurological disorders. The study will provide insight in the feasibility of REACTION. Participants will: * Participate in two sessions in which every session contains a walking task and balance tasks * end the study with a semi-structured interview
Detailed description
The first day will be focusing on 4 conditions: tasks without aid, tasks with regular aid, task with the ABLE Regain and tasks with REACTION. The first and third condition consist of a walking task and balance tasks, The second and fourth condition is only focusing on the walking task with the aim of getting familiar to the device and the walking task. The second day will also be focusing on four conditions: tasks without aid, tasks with aid, tasks with the GABLE Core and task with REACTION (Fig 3.2). The conditions 'tasks without aid', 'tasks with the GABLE Core' and 'tasks with REACTION' consist of a walking task and balance tasks (similar to day 1). The condition 'tasks with aid' only consists of a walking task. A semi-structured interview with the corresponding physiotherapist and patient will be held to gather more information about usability and feasibility of REACTION from a therapist's and patient's perspective.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | REACTION | Combination of a exoskeleton and gait trainer |
| DEVICE | ABLE Regain | Exoskeleton |
| DEVICE | GABLE Core | Gait trainer |
Timeline
- Start date
- 2025-04-01
- Primary completion
- 2026-01-01
- Completion
- 2026-01-01
- First posted
- 2025-02-03
- Last updated
- 2025-02-12
Locations
2 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT06805500. Inclusion in this directory is not an endorsement.